Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Operating Expenses (2017 - 2026)

Updated

Summit Therapeutics (SMMT) posted Operating Expenses of $220.5 million for Q2 2026, down 61.2% from $568.44 million a year earlier but up 13.0% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Operating Expenses (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Summit Therapeutics was $874.84 million, up 15.2% year-over-year; for FY2025, it was $1.09 billion, up 384.3% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of 71.7% (FY2020 to FY2025).
  • In prior years, Summit Therapeutics' Operating Expenses was $226 million in FY2024 (-62.9%), $609.65 million in FY2023 (+599.1%), $87.21 million in FY2022 (-20.0%) and $108.96 million in FY2021 (+48.5%).
  • Quarterly Operating Expenses has run from a low of $15.77 million in Q2 2023 to a high of $568.44 million in Q2 2025 over five years.
  • On a year-over-year basis, Operating Expenses increased in seven of the last eight quarters, with growth averaging 231.6%.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2025, with growth of 853.5%; the weakest was Q1 2024, with a decline of 92.1%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $195.21 million (Q1 2026), $224.93 million (Q4 2025) and $234.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Summit Therapeutics 12.28 Bn 10.04 Bn - 220.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 220.50 Mn
Mar 31, 2026 195.21 Mn
Dec 31, 2025 224.93 Mn
Sep 30, 2025 234.21 Mn
Jun 30, 2025 568.44 Mn
Mar 31, 2025 66.85 Mn
Dec 31, 2024 65.61 Mn
Sep 30, 2024 58.38 Mn
Jun 30, 2024 59.62 Mn
Mar 31, 2024 42.39 Mn
Dec 31, 2023 35.39 Mn
Sep 30, 2023 20.76 Mn
Jun 30, 2023 15.77 Mn
Mar 31, 2023 537.74 Mn
Dec 31, 2022 21.43 Mn
Sep 30, 2022 22.62 Mn
Jun 30, 2022 15.94 Mn
Mar 31, 2022 27.22 Mn
Dec 31, 2021 30.89 Mn
Sep 30, 2021 25.61 Mn
API Access

Summit Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=SMMT&period=max&api_key=YOUR_API_KEY